PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
14.66%
Some net income increase while MCHP is negative at -7.87%. John Neff would see a short-term edge over the struggling competitor.
-2.06%
Negative yoy D&A while MCHP is 3.50%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
12.28%
Lower deferred tax growth vs. MCHP's 572.54%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-21.43%
Both cut yoy SBC, with MCHP at -2.97%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
231.82%
Slight usage while MCHP is negative at -148.22%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-17.50%
AR is negative yoy while MCHP is 474.03%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
378.05%
Some inventory rise while MCHP is negative at -147.70%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-41.18%
Both negative yoy AP, with MCHP at -103.33%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
358.10%
Some yoy usage while MCHP is negative at -401.77%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-23.08%
Negative yoy while MCHP is 50.38%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
71.83%
Some CFO growth while MCHP is negative at -3.75%. John Neff would note a short-term liquidity lead over the competitor.
-11.20%
Negative yoy CapEx while MCHP is 5.40%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
11.20%
Less M&A spending yoy vs. MCHP's 91.67%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
50.05%
Some yoy expansion while MCHP is negative at -108.47%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
13.95%
At 50-75% of MCHP's 21.38%. Martin Whitman questions partial disadvantage if competitor monetizes investments more efficiently.
-14.78%
We reduce yoy other investing while MCHP is 7.30%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
323.56%
Investing outflow well above MCHP's 36.81%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-200.00%
Both yoy lines negative, with MCHP at -6.53%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
-31.37%
Negative yoy issuance while MCHP is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-20.80%
We cut yoy buybacks while MCHP is 25.63%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.